|
Originally published In Press as doi:10.1074/jbc.M310801200 on August 31, 2004
J. Biol. Chem., Vol. 279, Issue 46, 48013-48023, November 12, 2004
The Transcriptional Repressor hDaxx Potentiates p53-dependent Apoptosis*
Monica Gostissa ,
Manuela Morelli ,
Fiamma Mantovani ,
Elisa Guida ,
Silvano Piazza ,
Licio Collavin ,
Claudio Brancolini¶,
Claudio Schneider ¶, and
Giannino Del Sal ||**
From the
Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie (LNCIB), Area Science Park, Padriciano 99, 34012, Trieste, Italy, Dipartimento di Biochimica, Biofisica e Chimica delle Macromolecole and ||Centro di Eccellenza di Biocristallografia, Università di Trieste, via Licio Giorgeri 1, 34100, Trieste, Italy, and ¶Dipartimento di Scienze e Tecnologie Biomediche, Università di Udine, Piazzale Kolbe 4, 33100, Udine, Italy
p53 and its homologues p73 and p63 are transcription factors that play an essential role in modulating cell cycle arrest and cell death in response to several environmental stresses. The type and intensity of these responses, which can be different depending on the inducing stimulus and on the overall cellular context, are believed to rely on the activation of defined subsets of target genes. The proper activation of p53 family members requires the coordinated action of post-translational modifications and interaction with several cofactors. In this study, we demonstrate that the multifunctional protein hDaxx interacts with p53 and its homologues, both in vitro and in vivo, and modulates their transcriptional activity. Moreover, we show that hDaxx, which has been implicated in several apoptotic pathways, increases the sensitivity to DNA damage-induced cell death and that this effect requires the presence of p53. Although hDaxx represses p53-dependent transcription of the p21 gene, it does not affect the activation of proapoptotic genes, and therefore acts by influencing the balance between cell cycle arrest and proapoptotic p53 targets. Our results therefore underline the central role of hDaxx in modulating the apoptotic threshold upon several stimuli and identify it as a possible integrating factor that coordinates the response of p53 family members.
Received for publication, October 1, 2003
, and in revised form, August 10, 2004.
* This work was supported in part by grants from the Associazione Italiana per la Ricerca sul Cancro, Consiglio Nazionale delle Ricerche, and Telethon (to G. D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed. Tel.: 39-040398992; Fax: 39-040398990; E-mail: delsal{at}area.trieste.it.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Guida, A. Bisso, C. Fenollar-Ferrer, M. Napoli, C. Anselmi, J. E. Girardini, P. Carloni, and G. Del Sal
Peptide Aptamers Targeting Mutant p53 Induce Apoptosis in Tumor Cells
Cancer Res.,
August 15, 2008;
68(16):
6550 - 6558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bodai, N. Pardi, Z. Ujfaludi, O. Bereczki, O. Komonyi, E. Balint, and I. M. Boros
Daxx-like Protein of Drosophila Interacts with Dmp53 and Affects Longevity and Ark mRNA Level
J. Biol. Chem.,
December 14, 2007;
282(50):
36386 - 36393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Gaddy and D. S. Lyles
Oncolytic Vesicular Stomatitis Virus Induces Apoptosis via Signaling through PKR, Fas, and Daxx
J. Virol.,
March 15, 2007;
81(6):
2792 - 2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, X. Wang, X. Wu, Y. Rui, W. Liu, J. Wang, X. Wang, Y.-C. Liou, Z. Ye, and S.-C. Lin
Daxx Cooperates with the Axin/HIPK2/p53 Complex to Induce Cell Death
Cancer Res.,
January 1, 2007;
67(1):
66 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Monte, M. Simonatto, L. Y. Peche, D. R. Bublik, S. Gobessi, M. A. Pierotti, M. Rodolfo, and C. Schneider
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents
PNAS,
July 25, 2006;
103(30):
11160 - 11165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lacroix, R.-A. Toillon, and G. Leclercq
p53 and breast cancer, an update.
Endocr. Relat. Cancer,
June 1, 2006;
13(2):
293 - 325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Frasca, A. Rustighi, R. Malaguarnera, S. Altamura, P. Vigneri, G. Del Sal, V. Giancotti, V. Pezzino, R. Vigneri, and G. Manfioletti
HMGA1 Inhibits the Function of p53 Family Members in Thyroid Cancer Cells.
Cancer Res.,
March 15, 2006;
66(6):
2980 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|